A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/1994
12/22/1994	WO1994029440A1 Generation, concentration and efficient transfer of vsv-g pseudotyped retroviral vectors
12/22/1994	WO1994029438A1 Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
12/22/1994	WO1994029436A1 Methods for selectively stimulating proliferation of t cells
12/22/1994	WO1994029330A1 Myeloid cell leukemia associated gene mcl-1
12/22/1994	WO1994028938A1 Adenovirus vectors for gene therapy sponsorship
12/22/1994	WO1994028797A1 Methods of preparing gas-filled liposomes
12/22/1994	WO1994028721A1 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity
12/22/1994	WO1994025588A3 ANTISENSE-OLIGONUCLEOTIDES FOR THE TREATMENT OF IMMUNOSUPPRESSIVE EFFECTS OF TRANSFORMING GROWTH FACTOR-β (TGF-β)
12/22/1994	WO1994025477A3 Novel peptide nucleic acids
12/22/1994	CA2164953A1 Retroviral vectors for transducing beta-globin gene and beta-locus control region derivatives
12/22/1994	CA2164632A1 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity
12/22/1994	CA2164288A1 Method for treating kaposi's sarcoma with antisense oligonucleotides
12/22/1994	CA2163905A1 Inhibiting protein interactions
12/22/1994	CA2162497A1 Adenoviral vectors for treatment of hemophilia
12/21/1994	EP0629129A1 Method for kidney tubulogenesis
12/21/1994	CN1096584A Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of hla-c-clone 10/mage-1 derived peptides, and method for treating said.........
12/08/1994	WO1994028391A1 Ligands for flt3 receptors
12/08/1994	WO1994028152A1 Defective adenoviruses and corresponding complementation lines
12/08/1994	WO1994028151A1 Gene therapy for haemophilia
12/08/1994	WO1994028128A1 Test and model for polycystic ovary syndrome and male pattern baldness
12/08/1994	WO1994027612A1 Genetic therapy for cardiovascular disease
12/08/1994	WO1994027435A1 Genetic immunization with cationic lipids
12/08/1994	WO1994027426A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases
12/07/1994	EP0627489A1 Methods and compositions for the treatment of malignancies in which a protein kinase is associated
12/07/1994	EP0627487A2 Ligands for FLT3 receptors
12/07/1994	EP0627001A1 MAMMALIAN Sos - A REGULATOR/EFFECTOR OF TYROSINE KINASE SIGNALLING
12/07/1994	EP0626852A1 Method for making universal donor cells
12/06/1994	US5371009 Enhancers
11/1994
11/30/1994	EP0626012A1 Homogenotization of gene-targeting events
11/28/1994	EP0663013A4 Method for delivering nucleic acids into cells.
11/24/1994	WO1994026915A1 Gene transfer into pancreatic and biliary epithelial cells
11/24/1994	WO1994026914A1 Adenoviral vectors of animal origin and use thereof in gene therapy
11/24/1994	WO1994026888A1 Inhibition of proliferation of vascular smooth muscle cell
11/24/1994	WO1994026887A1 Antisense oligonucleotides which combat aberrant splicing and methods of using the same
11/24/1994	WO1994026877A1 Ribozyme gene therapy for hiv infection and aids
11/24/1994	WO1994026307A1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
11/24/1994	WO1994026289A1 Allogeneic and xenogeneic transplantation
11/24/1994	WO1994026285A1 Xenograft thymus
11/24/1994	WO1994016073A3 Methods and reagents for inhibiting furin endoprotease
11/24/1994	CA2500213A1 Gene transfer into pancreatic and biliary epithelial cells
11/24/1994	CA2163234A1 Inhibition of proliferation of vascular smooth muscle cell
11/24/1994	CA2163129A1 Ribozyme gene therapy for hiv infection and aids
11/24/1994	CA2162602A1 Gene transfer into pancreatic and biliary epithelial cells
11/24/1994	CA2162496A1 Allogeneic and xenogeneic transplatation
11/24/1994	CA2161797A1 Xenograft thymus
11/23/1994	EP0625207A1 Gene therapy for cystic fibrosis transmembrane conductance regulator activity (cftr)
11/23/1994	EP0625206A1 Human epidermal gene promoter
11/23/1994	EP0625204A1 Hepatitis therapeutics
11/23/1994	EP0625195A1 Therapy of central nervous system by genetically modified cells
11/23/1994	EP0625192A1 Nucleozymes
11/23/1994	EP0625049A1 Ex vivo gene transfer
11/23/1994	EP0625007A1 Gene transfer in birds by introduction of dna into muscle in ovo
11/22/1994	US5367056 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
11/17/1994	EP0624195A1 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides
11/17/1994	EP0624100A1 Dna encoding a human serotonin receptor (5-ht 4b?) and uses thereof
11/10/1994	WO1994025608A1 Natural or recombinant dna binding proteins as carriers for gene transfer or gene therapy
11/10/1994	WO1994025601A2 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
11/10/1994	WO1994025588A2 ANTISENSE-OLIGONUCLEOTIDES FOR THE TREATMENT OF IMMUNOSUPPRESSIVE EFFECTS OF TRANSFORMING GROWTH FACTOR-β (TGF-β)
11/10/1994	WO1994025477A2 Novel peptide nucleic acids
11/10/1994	WO1994025073A1 Recombinant viruses and their use in gene therapy
11/10/1994	WO1994024870A1 Retroviral vectors capable of expressing multimeric proteins from multiple translational initiation sites
11/10/1994	WO1994024864A1 Methods of preventing viral replication
11/10/1994	WO1994023048A3 Gibbon ape leukemia virus-based retroviral vectors
11/10/1994	WO1994021781A3 Extracellular signal-regulated kinase, sequences, and methods of production and use
11/10/1994	WO1994012649A3 Gene therapy for cystic fibrosis
11/10/1994	WO1994003075A3 Morphogen-enriched dietary composition
11/10/1994	CA2662090A1 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
11/10/1994	CA2162056A1 Retroviral vectors capable of expressing multimeric proteins from multiple translational initiation sites
11/10/1994	CA2161679A1 Recombinant virus and their use in genic therapy
11/10/1994	CA2161230A1 Novel peptide nucleic acids
11/09/1994	EP0623628A1 Muscular dystrophy gene products, antibodies thereto and methods for immunodiagnosis of muscular dystrophy
11/09/1994	EP0623171A1 Enzymatic rna molecules
11/09/1994	EP0623025A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
11/02/1994	EP0621786A1 Induced tolerance to xenografts
11/01/1994	US5360735 DNA encoding a human 5-HT1F receptor, vectors, and host cells
10/1994
10/27/1994	WO1994024300A1 Transposition assembly for gene transfer in eukaryotes
10/27/1994	WO1994024299A1 Adenovirus for the transfer of foreign dna into higher eucaryotic cells
10/27/1994	WO1994024298A1 Biocompatible implant for the expression and secretion in vivo of a therapeutical compound
10/27/1994	WO1994024297A1 Defective recombinant adenoviruses for gene therapy of tumours
10/27/1994	WO1994024277A1 Protection of human bone marrow from high dose antifolate therapy using mutated human dihydrofolate reductase dna
10/27/1994	WO1994024143A1 Method of forming oligonucleotides
10/27/1994	WO1994023756A1 Neural thread protein gene expression and detection of alzheimer's disease
10/27/1994	WO1994023754A1 Use of neuro-derived fetal cell lines for transplantation therapy
10/27/1994	WO1994023738A1 Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression
10/27/1994	WO1994023701A1 Particulate vector and pharmaceutical composition containing such vector
10/27/1994	WO1994023699A1 Long-acting treatment by slow-release delivery of antisense oligodeoxyribonucleotides from biodegradable microparticles
10/27/1994	WO1994023582A1 Adenoviral vectors including dna encoding lung surfactant protein
10/27/1994	CA2161122A1 Biocompatible implant for expression and secretion of a therapeutic compound in vivo
10/27/1994	CA2161121A1 Particulate vector and pharmaceutical composition containing the same
10/27/1994	CA2161097A1 Neural thread protein gene expression and detection of alzheimer's disease
10/27/1994	CA2160878A1 Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression
10/27/1994	CA2160877A1 Long-acting treatment by slow-release delivery of antisense oligodeoxyribonucleotides from biodegradable microparticles
10/27/1994	CA2160697A1 Transposition kit for gene transfer in eukaryotes
10/27/1994	CA2160136A1 Adenoviral vectors including dna encoding lung surfactant protein
10/27/1994	CA2159738A1 Use of neuro-derived fetal cell lines for transplantation therapy
10/26/1994	EP0620741A1 Cytotoxic drug therapy
10/25/1994	US5359051 Compounds useful in the synthesis of nucleic acids capable of cleaning RNA
10/25/1994	US5358866 Using cytosine deaminase as marker
10/19/1994	EP0620277A1 Nucleic acid pharmaceuticals
10/19/1994	EP0619838A1 Repopulation of testicular seminiferous tubules with foreign cells

1 ... 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 ... 870